The clinical performance is complex and often involves multiple systemic strain. Early identification and standardized diagnosis are essential for improving prognosis. The diagnosis of the disease requires a combination of clinical performance, imaging inspection, laboratory testing and pathological activation.
The platform can assist in matching teams of authoritative experts at home and abroad to provide accurate diagnosis and treatment programs. In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, many autoimmune and rheumatic immune diseases that have previously been difficult to treat have been significantly improved. Treatment requires close monitoring of therapeutic efficacy and adverse reactions and timely adaptation to the changes in the condition.
Multidisciplinary collaboration (MDT) is particularly important for the comprehensive management of disorders associated with anti-synthetase syndrome. The platform serves China International Medical Service System, a team of authoritative experts at home and abroad in the field of autoimmune and rheumatic immunity, to provide the following services to patients: 1. 2.
Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.